|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM354397958 |
| 003 |
DE-627 |
| 005 |
20231226062132.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202211059
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1181.xml
|
| 035 |
|
|
|a (DE-627)NLM354397958
|
| 035 |
|
|
|a (NLM)36934404
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Leng, Yubing
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Advances in In Vitro Models of Neuromuscular Junction
|b Focusing on Organ-on-a-Chip, Organoids, and Biohybrid Robotics
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 23.10.2023
|
| 500 |
|
|
|a Date Revised 23.10.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley-VCH GmbH.
|
| 520 |
|
|
|a The neuromuscular junction (NMJ) is a peripheral synaptic connection between presynaptic motor neurons and postsynaptic skeletal muscle fibers that enables muscle contraction and voluntary motor movement. Many traumatic, neurodegenerative, and neuroimmunological diseases are classically believed to mainly affect either the neuronal or the muscle side of the NMJ, and treatment options are lacking. Recent advances in novel techniques have helped develop in vitro physiological and pathophysiological models of the NMJ as well as enable precise control and evaluation of its functions. This paper reviews the recent developments in in vitro NMJ models with 2D or 3D cultures, from organ-on-a-chip and organoids to biohybrid robotics. Related derivative techniques are introduced for functional analysis of the NMJ, such as the patch-clamp technique, microelectrode arrays, calcium imaging, and stimulus methods, particularly optogenetic-mediated light stimulation, microelectrode-mediated electrical stimulation, and biochemical stimulation. Finally, the applications of the in vitro NMJ models as disease models or for drug screening related to suitable neuromuscular diseases are summarized and their future development trends and challenges are discussed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a biohybrid robotics
|
| 650 |
|
4 |
|a neuromuscular diseases
|
| 650 |
|
4 |
|a neuromuscular junctions
|
| 650 |
|
4 |
|a organ-on-a-chip
|
| 650 |
|
4 |
|a organoids
|
| 700 |
1 |
|
|a Li, Xiaorui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zheng, Fuyin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Hui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Chunyan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Xudong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liao, Yulong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Jiangyue
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Meng, Kaiqi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yu, Jiaheng
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Jingyi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Binyu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tan, Yingjun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Meili
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jia, Xiaoling
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Deyu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Yinghui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Gu, Zhongze
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Fan, Yubo
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 35(2023), 41 vom: 19. Okt., Seite e2211059
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:35
|g year:2023
|g number:41
|g day:19
|g month:10
|g pages:e2211059
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202211059
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 35
|j 2023
|e 41
|b 19
|c 10
|h e2211059
|